Profile data is unavailable for this security.
About the company
Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation, and good manufacturing practices (GMP) manufacturing facilities are in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.
- Revenue in AUD (TTM)17.52m
- Net income in AUD-51.24m
- Incorporated2015
- Employees40.00
- LocationCann Group LtdGround Floor262-276 Lorimer Street, PortMELBOURNE 3207AustraliaAUS
- Phone+61 39095-7088
- Websitehttps://www.canngrouplimited.com/